Aadi Bioscience Stock Market Capitalization
| AADIDelisted Stock | USD 2.05 0.10 4.65% |
Aadi Bioscience fundamentals help investors to digest information that contributes to Aadi Bioscience's financial success or failures. It also enables traders to predict the movement of Aadi Stock. The fundamental analysis module provides a way to measure Aadi Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aadi Bioscience stock.
Aadi |
Aadi Bioscience Company Market Capitalization Analysis
Aadi Bioscience's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Aadi Bioscience Market Capitalization | 97.21 M |
Most of Aadi Bioscience's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aadi Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Aadi Bioscience is about 97.21 M. This is 99.25% lower than that of the Biotechnology sector and 97.95% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.49% higher than that of the company.
Aadi Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aadi Bioscience's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aadi Bioscience could also be used in its relative valuation, which is a method of valuing Aadi Bioscience by comparing valuation metrics of similar companies.Aadi Bioscience is currently under evaluation in market capitalization category among its peers.
Aadi Fundamentals
| Return On Equity | -0.66 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (2.46) % | |||
| Operating Margin | (1.49) % | |||
| Current Valuation | 35.53 M | |||
| Shares Outstanding | 46.29 M | |||
| Shares Owned By Insiders | 6.09 % | |||
| Shares Owned By Institutions | 50.02 % | |||
| Number Of Shares Shorted | 764.36 K | |||
| Price To Book | 1.41 X | |||
| Price To Sales | 3.88 X | |||
| Revenue | 24.35 M | |||
| Gross Profit | (27.54 M) | |||
| EBITDA | (65.36 M) | |||
| Net Income | (65.77 M) | |||
| Cash And Equivalents | 118.74 M | |||
| Cash Per Share | 5.65 X | |||
| Total Debt | 1.27 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 9.87 X | |||
| Book Value Per Share | 2.80 X | |||
| Cash Flow From Operations | (59.66 M) | |||
| Short Ratio | 8.87 X | |||
| Earnings Per Share | (2.28) X | |||
| Target Price | 3.0 | |||
| Number Of Employees | 53 | |||
| Beta | 0.34 | |||
| Market Capitalization | 97.21 M | |||
| Total Asset | 132.42 M | |||
| Retained Earnings | (268.96 M) | |||
| Working Capital | 98.19 M | |||
| Net Asset | 132.42 M |
About Aadi Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aadi Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aadi Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aadi Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Aadi Stock
If you are still planning to invest in Aadi Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aadi Bioscience's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |